FIGURE 1.
Trial design for ACHIEVE I and ACHIEVE II trials. mITT, modified intent‐to‐treat. Ubrogepant 25 and 100 mg dose groups were not available in both trials and not included in this pooled analysis
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.